Latest News and Press Releases

PRESS RELEASE OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress Move to new purpose-built 16,000ft2 flagship site on ARC...

PRESS RELEASE Publication in Nature Chemistry Demonstrates the Benefits of Native Mass Spectrometry in the Interrogation of Target Ecosystems and Drug Discovery Joint publication in Nature...

PRESS RELEASE OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases Financing led by new investors, GV, Northpond Ventures and Sanofi...

PRESS RELEASE Publication in Nature by OMass Founder, Professor Dame Carol Robinson, Shows Power of Native Mass Spectrometry in Drug Discovery by Capturing GPCR Signalling in Native Membrane...

PRESS RELEASE OMass Establishes Scientific Advisory Board of Leading Experts in the Use of Biophysical Approaches to Drug Discovery Oxford, United Kingdom – 7 March 2022 – OMass Therapeutics...

PRESS RELEASE OMass’s OdyssION™ Drug Discovery Platform Makes Progress in Drugging the Undruggable, including Gasdermin D Oxford, United Kingdom – 28 February 2022 – OMass Therapeutics (‘OMass’ or...

PRESS RELEASE OMass Therapeutics to Present at Upcoming Conferences Oxford, United Kingdom – 21 February 2022 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying...

PRESS RELEASE OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable or Inadequately Drugged Membrane and Complex-bound Proteins Oxford, United Kingdom – 4 November 2021 – OMass...